To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Catalyst Capital adds to investment in Evolve Biologics
Evolve Biologics, the plasma-derived therapeutics affiliate of Toronto-based Therapure Biopharma, has raised financing from majority investor Catalyst Capital Group.
